Methods of screening for ltrpc7 modulators
CA 2428698 C · Owner: Fleig, Andrea · Inventors: Penner, Reinhold; Fleig, Andrea
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the identification and isolation of a novel family of ATP regulated calcium transmembrane channel polypeptides designated herein as "LTRPC7" (Long Transient Receptor Potential Channel). Channels comprising these polypeptides close in response to concentrations of cytoplasmic ATP in the millimolar range are subject to inhibition by high , intracellular levels of calcium and/or magnesium and do not respond to , depletion or reduction in intracellular calcium stores. The invention further relates to the methods of utilizing LTRPC7 for binding and the methods for , modulating LTRPC7 activity and for measuring LTRPC2 permeability. The invention further …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 13, 2001 and granted August 21, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 13, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 13, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.